Senior Oncology Account Specialist - Field Sales & Impact

Pfizer; Green Bay (WI); On-site; USD 109,000 - 251,000; Full time

Benefits offered by this job

401(k) with Pfizer Matching Contribs.

Pfizer Retirement Savings Contribution

Health, dental, vision benefits

Job summary

Pfizer is seeking a Senior Oncology Account Specialist to promote our oncology portfolio and educate healthcare providers on appropriate use of Pfizer therapies. The role covers calls on high-value accounts to improve patient care and strengthen relationships with key opinion leaders within the Green Bay area.

You will translate account landscapes into strategic plans, leverage Pfizer resources, and drive growth across a growing oncology portfolio while maintaining high ethical and scientific

Qualifications

• Experience promoting oncology products to healthcare providers.
• Ability to communicate complex scientific information to diverse customers.
• Proven success in pharmaceutical sales or healthcare professional engagement.

Responsibilities

• Promote Pfizer’s oncology portfolio to healthcare providers and specialists.
• Educate the healthcare community on appropriate use of Pfizer products.
• Call on accounts and organized customers to improve patient experience.
• Link account assessments with Pfizer resources to increase brand impact.

Skills

Pharmaceutical sales experience

Oncology sales experience

Executive communication

Strategic account management

Business acumen

Digital tools proficiency

Education

BA/BS Degree from an accredited institution

Associate’s degree + 8+ years experience

High school diploma + 10+ years relevant experience

Job description

Pfizer is seeking a Senior Oncology Account Specialist to promote our oncology portfolio and educate healthcare providers on appropriate use of Pfizer therapies. The role covers calls on high-value accounts to improve patient care and strengthen relationships with key opinion leaders within the Green Bay area.

You will translate account landscapes into strategic plans, leverage Pfizer resources, and drive growth across a growing oncology portfolio while maintaining high ethical and scientific